Sharon Kheradnam

Sharon Kheradnam practices at Corona Medical in Elmhurst, New York.

Sharon Kheradnam's NPI, 1063823664, was assigned on May 16, 2014. Sharon Kheradnam holds New York license 291764.

Sharon Kheradnam's primary practice is Corona Medical, at 40-11 Warren St, Elmhurst, NY 11373 in Queens County. The practice phone is (718) 426-8100.

Sharon Kheradnam's primary practice is Corona Medical in Elmhurst, New York. The medical group on file is Corona Medical PC. Dmand AI also links Sharon Kheradnam to 2 more group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sharon Kheradnam practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Sharon Kheradnam's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Sharon Kheradnam is licensed in New York.

CMS data shows 329 Medicare services from Sharon Kheradnam across 9 procedure codes in 2024, for 68 Medicare patients. Medicare paid $20,952 for them. Every service was in an office.

CMS counts 68 Medicare patients who saw Sharon Kheradnam in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 74% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sharon Kheradnam's median patient age at 38, with 48% women.

In 2024, Sharon Kheradnam wrote 976 Medicare Part D claims for 72 patients. 80% of them were for generic drugs. CMS names the drug for 669 of them, across 27 drugs with 11 or more claims each, at $65,040 in total drug cost. In 2023, CMS named 496 claims across 24 drugs.

Sharon Kheradnam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sharon Kheradnam as offering telehealth.

Dmand AI links 1 paper to Sharon Kheradnam in 2016.

CMS Open Payments shows 21 general payments to Sharon Kheradnam from 12 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $497.